Intuitive Ventures is the venture capital arm of Intuitive (Nasdaq: ISRG), headquartered in Sunnyvale, Calif. Through its inaugural $100 million fund, Intuitive Ventures invests in and is advancing the digital, device, therapeutic and diagnostic ecosystems of minimally invasive care and beyond, fostering a disciplined and sustainable investment platform that will offer strategic and financial returns for the long term. Building on Intuitive's entrepreneurial beginnings as a medtech and healthcare success story in Silicon Valley, and as a digitally native company, Intuitive Ventures is well-positioned to identify and support early-stage innovators meeting that challenge.
External link for Intuitive Ventures
Sunnyvale, CA 94086, US
Congratulations Endogenex on the $88M Series C. With this funding, the company will complete its ReCET Clinical Study, bringing us closer to transforming care for type 2 diabetes patients. Intuitive Ventures is proud to participate in the round.
Exciting times at Endogenex. We are proud to announce the completion of our $88 million Series C financing. Congratulations to the team! https://lnkd.in/dprt3Spy #ReCET #type2diabetes #endocrinology #gastroenterology #endogenex
Welcome to the team, Vijay Rajasekhar, MD, MBA! Vijay joins Intuitive Ventures as an Associate. Learn more about Vijay's career journey and how he came to the Intuitive Ventures team here:
Congratulations Amber Therapeutics on the raise of a $100M Series A. Learn more our investment in the company and how Amber is poised to treat female mixed urinary incontinence:
HLTH Europe is only a few weeks away. The inaugural event, taking place from 17-20 June in Amsterdam, will connect leaders from over 50 countries from every part of the European health ecosystem. If you're attending, check out Murielle Thinard McLane's panel, "Silicon & scalpels: The new age of surgery" on June 19. https://lnkd.in/dPU55jE8
If you missed #LSIUSA24 this year, check out Murielle Thinard McLane's panel discussing CVC's role within the medtech landscape and what she looks for when investing in a startups. https://lnkd.in/eedDejq3
Intuitive Ventures reposted this
How should European Medtech startups approach entering the US market? In this clip, Murielle Thinard McLane, Managing Partner at Intuitive Ventures, shares her observations on how companies are tackling this and provides guidance for those aiming to break into the US market. Hear more from both US and European based investors as they discuss European and US investment dynamics in the #LSIEurope23 panel, ‘Transatlantic Investment & Innovation: Juxtaposing European & US Dynamics for Investing in, Building, & Scaling Companies.’ Featured Panelists: • Mano Iyer, Partner, Sofinnova Partners (Moderator) • Sascha Berger, General Partner at TVM Capital Life Science • Janke Dittmer, General Partner, Gilde Healthcare • Murielle Thinard McLane, Managing Partner, Intuitive Ventures • Vijay Barathan, MD, Partner, Optum Ventures The full panel is available on our website and YouTube channel. Registration and applications to present are open for LSI Europe ‘24 this September 16th - 20th at the Penha Longa Resort, in Portugal. Secure your spot today to ensure you get the best rate and secure a hotel room onsite.
Last month, Vivian Emmely Golfin, MD spoke on a panel hosted by Stanford Byers Center for Biodesign discussing the role of biodesign in business development and corporate VC. The engaging conversation also featured leaders from Johnson & Johnson, Stryker and Edwards Lifesciences. Thanks to all who participated!
Murielle Thinard McLane will be leading a roundtable discussion at the 8th Annual Rosenman Symposium on May 21-22 at the UCSF Rosenman Institute, where she will discuss the latest challenges and innovations in healthcare. Be sure to save your spot to attend: https://lnkd.in/gbXvGZtE #RosenmanSymposium
LSI Emerging Medtech Summit kicked off yesterday, bringing together the industry's brightest minds and biggest leaders. Murielle Thinard McLane was featured on a panel alongside Orchestra BioMed, Dexcom, Boston Scientific and Medtronic discussing CVC's role within the ecosystem.
Tomorrow, Murielle Thinard McLane will discuss the future of minimally invasive care with executives from Bionaut Labs and Horizon Surgical Systems at #UCLAMedTech2024. If you're attending, be sure to catch Murielle's panel at 2:30pm.
Let's #bringiton #energy #endoscopy #robotics Don't miss #uclamedtech2024 Next Tuesday 3/12 Register now https://ucla.in/3wtYQG6 UCLA Health Bionaut Labs #horizonsurgical Intuitive